Glucagon News

← Back to News Overview


Glucagon currently has 0 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Glucagon with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
  • Original indication: Baqsimi is indicated for the treatment of severe hypoglycaemia in adults, adolescents, and children aged 4 years and over with diabetes mellitus.
  • Evidence level: L5
  • Predicted indications (20):
    • irritable bowel syndrome (99.2%)
    • cauda equina syndrome (98.8%)
    • obsolete neurogenic bladder (disease) (97.3%)
    • acute laryngopharyngitis (94.5%)
    • nasal cavity disease (94.3%)
    • pharyngitis (93.8%)
    • primary hereditary glaucoma (91.0%)
    • open-angle glaucoma (90.2%)
    • filariasis (90.0%)
    • large intestine disease (89.9%)
    • small intestine disease (89.2%)
    • obsolete rare pulmonary disease (89.2%)
    • gastroenteritis (89.2%)
    • pulmonary edema (88.1%)
    • dermatitis (86.3%)
    • esotropia (86.0%)
    • pityriasis simplex (85.0%)
    • seborrheic dermatitis (84.9%)
    • acrodermatitis chronica atrophicans (84.2%)
    • rhinitis (84.0%)

View full drug report →

No related news yet. When news mentions this drug, it will be collected and shown here automatically.

Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.

Copyright © 2026 藥提醒科技有限公司 (yao.care). For research purposes only. Not medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.